A Losing Bidder Forced Poland's National Film Culture Centre to Redo Its Museum Exhibition Tender, But the Same Winner Came Out on Top
14 Aug 2026
Standfirst EC1 Łódź, the cultural institution behind Poland's National Centre of Film Culture, has awarded a PLN 11 036 052 contract to build its "Mechanical Eye" exhibition to New Amsterdam Sp. z o.o., after a rival bidder's formal appeal forced the buyer to annul its first decision and redo the evaluation. The second attempt reached the same result. Introduction Building a museum exhibition is not just carpentry and cabling. It is display cases built to precise technical drawings, multimedia stations wired into existing building systems, lighting calibrated to the millimetre, and, in this case, a formal legal fight over how a Polish cultural institution scored the bids in front of it. EC1 Łódź - Miasto Kultury w Łodzi, the organisation behind Poland's National Centre of Film Culture, ran a tender to build its new "Mechanical Eye" exhibition, exploring the mechanical history of image capture. A losing bidder challenged the result before Poland's National Appeals Chamber, won a partial victory and forced the buyer to start its evaluation over. The outcome, in the end, did not change. Why This Contract Matters This is an EU co-financed cultural infrastructure project, funded under Poland's European Funds for Infrastructure, Climate and Environment 2021-2027 programme, specifically supporting the expansion of the National Centre of Film Culture's cultural and educational offering through what the funding documentation calls the "Mechanical Eye stage." That gives a fairly technical fit-out contract genuine public significance as part of a larger, EU backed cultural investment. The legal dispute woven through this notice is also instructive. A formal challenge that succeeds, even partially and forces a contracting authority to redo its evaluation is a meaningful check on how public bodies score complex, subjective criteria like design quality and this case shows both that check working and its limits: procedural fairness was enforced, but the original commercial outcome held. Contract Timeline Original tender notice referenced by this procedure: 37139-2026 Appeal filed with the National Appeals Chamber: 9 April 2026 Appeals Chamber ruling (case KIO 1626/26): 27 May 2026 Contract concluded: 24 July 2026 Notice dispatched to the Publications Office: 13 August 2026 Published in the Official Journal, OJ S 156/2026: 14 August 2026 Contract Overview EC1 Łódź ran an open procedure under Directive 2014/24/EU for the design, supply, installation and commissioning of the "Mechanical Eye" exhibition, covering display cases, multimedia stations, exhibition furniture, graphic design and visual identity, an exhibition management system and a content management system, all integrated with the venue's existing building infrastructure. Three tenders were received and New Amsterdam Sp. z o.o. was selected, submitting both the lowest priced bid and the ultimate winning offer at PLN 11 036 052.00, against a range running up to PLN 13 224 551.64 for the highest tender. Before reaching this final result, the process was interrupted. A rival bidder, TDC Polska Sp. z o.o., filed a formal appeal with Poland's National Appeals Chamber challenging the evaluation and the Chamber partially upheld it, ordering EC1 Łódź to annul its original selection and repeat the assessment with fuller justification of its quality scoring. The buyer did so and New Amsterdam was selected again. Key Contract Details Contracting authorityEC1 Łódź – Miasto Kultury w Łodzi Contract titleExecution of the "Mechanical Eye" exhibition, with multimedia equipment, software and exhibition management system CPV code32321200, Audio-visual equipment, plus codes covering exhibition equipment, display cases, multimedia software and related services Procedure typeOpen procedure Legal basisDirective 2014/24/EU Estimated valuePLN 10 732 130.66, excluding VAT Awarded valuePLN 11 036 052.00, excluding VAT Award criteriaPrice 60 percent; quality of exhibition fixture execution 25 percent; functional-graphic concept quality 15 percent Tenders received3, all electronic, all from SMEs WinnerNew Amsterdam Sp. z o.o. Winner size classificationSmall enterprise SubcontractingYes, value and percentage not disclosed Contract signed24 July 2026 Warranty terms24 months generally, 36 months for equipment EU fundingYes, European Funds for Infrastructure, Climate and Environment 2021-2027 Framework structureNo framework agreement, direct contract Formal review filedYes, by TDC Polska Sp. z o.o., partially upheld Review bodyKrajowa Izba Odwoławcza (National Appeals Chamber) Notice reference564089 2026, OJ S 156/2026, published 14 August 2026 Project Scope The contractor must design, supply, install and commission every physical and digital element of the exhibition: display cases and multimedia stations, furniture and arrangement elements across the exhibition and its foyer, lighting connected and calibrated to the venue's existing electrical and low voltage networks and the physical mounting of museum objects in cases, pedestals and displays according to project specifications. The scope also covers the exhibition's full graphic design and visual identity system, coordination with the separate construction contractor where existing arrangement elements need to be adjusted, workshop and as-built documentation and any supplementary design work needed for the exhibition to function. A distinctive technical requirement ran through the tender itself: bidders had to submit physical evaluation samples alongside their bids, including a fragment of a display case with a glass dome built to a specific technical drawing and a functional graphic concept for a station described as "Digital Camera," part of the Mechanical Eye exhibition, both assessed under the tender's quality criteria. The winning contractor must also deliver and commission an Exhibition Management System and a Content Management System, integrated with the venue's existing building systems and provide a 24 month warranty overall, extended to 36 months for equipment specifically. About the Contracting Authority EC1 Łódź – Miasto Kultury w Łodzi is a local authority based in Łódź, active in recreation, culture and religion. EC1 Łódź operates as a major cultural institution housed in a former power station complex and this project forms part of the National Centre of Film Culture's expansion, financed through a co-financing agreement dated 25 April 2024 under Poland's European Funds for Infrastructure, Climate and Environment 2021-2027 programme, specifically its Action 7.1 supporting culture and cultural tourism infrastructure. About the Organisations Involved EC1 Łódź - Miasto Kultury w Łodzi As covered above, EC1 Łódź is the buyer behind this contract, responsible for delivering the EU co-financed Mechanical Eye exhibition as part of the National Centre of Film Culture's broader expansion. Krajowa Izba Odwoławcza Poland's National Appeals Chamber, based in Warsaw, is the review body for this contract and the body that heard and partially upheld TDC Polska's formal appeal, ordering EC1 Łódź to annul its original evaluation and redo the assessment with fuller documentation of its quality scoring. New Amsterdam Sp. z o.o. New Amsterdam Sp. z o.o., based in Kraków and classified as a small enterprise, is the winning contractor, having submitted both the lowest priced and ultimately highest ranked bid across both rounds of evaluation. TDC Polska Sp. z o.o. TDC Polska Sp. z o.o., based in Suchy Las near Poznań, is the unsuccessful tenderer whose formal appeal, filed 9 April 2026, forced EC1 Łódź to annul its original award decision. The appeal challenged the evaluation process itself, the buyer's decision not to reject bids from New Amsterdam and a third tenderer, Trias AVI Sp. z o.o., the selection of the winning offer, the rejection of TDC Polska's own bid and the adequacy of the documentation behind the buyer's quality criteria scoring. Trias AVI Sp. z o.o. Trias AVI Sp. z o.o. was the third tenderer in this procurement, named in TDC Polska's appeal as a bid the appellant argued should have been rejected, though the Appeals Chamber's ruling did not uphold that specific claim. Procurement Analysis The tender combined a 60 percent price criterion with two quality criteria worth a combined 40 percent, both evaluated through physical or written samples submitted alongside each bid rather than through written proposals alone, a rigorous approach for assessing exhibition fabrication quality and multimedia design concept before any contract is signed. New Amsterdam's win with the lowest of three prices suggests its quality scores were also competitive, since price alone at 60 percent would not guarantee victory without adequate quality performance. The formal legal challenge is the most significant procedural element of this notice. TDC Polska's appeal was only partially successful: the Appeals Chamber rejected its arguments about specific bids needing rejection, but agreed that EC1 Łódź had not adequately documented the factual basis for the quality scores it awarded across all non-price criteria. That is a meaningful, if narrow, finding, one that speaks to the ongoing challenge public buyers face justifying subjective quality assessments in a way that withstands scrutiny. Ordered to redo its evaluation with better documentation, EC1 Łódź reached an identical result, suggesting the original substantive scoring was sound even if its written justification initially fell short. Three tenders for a specialised museum fit-out contract of this kind is a reasonable, healthy field and the narrow price range among admissible bids, from roughly PLN 11 million to PLN 13.2 million, suggests all three competitors had a broadly similar view of what the work should cost. Additional Procurement Facts The contract's award value of PLN 11 036 052.00 came in about 2.8 percent above the original PLN 10 732 130.66 estimate, a modest and unremarkable variance. The tender required exclusion declarations under the EU's Russia sanctions regulation and Poland's law on countering support for aggression against Ukraine, standard conditions in current Polish public procurement. Bidders were required to submit evaluation samples in a mix of electronic and, for one physical sample, in-person formats delivered directly to the buyer's premises. Personnel performing installation work must be employed under formal employment contracts under Polish procurement law, rather than other work arrangements. Market and Industry Perspective Museum and exhibition fit-out is a specialised niche within the broader construction and multimedia integration market, requiring firms to combine cabinetry and display fabrication skill with software integration and AV systems expertise, exactly the combination tested by this tender's dual sample requirements. The presence of three credible competitors for a contract of this technical complexity points to a reasonably developed specialist market in Poland for this kind of cultural sector work. Economic Significance At just over PLN 11 million, this is a modest contract by national infrastructure standards, but it represents a meaningful, EU co-financed investment in expanding Poland's National Centre of Film Culture, adding a purpose built exhibition exploring the mechanical history of image capture to the institution's cultural offering. Future Procurement Opportunities As EC1 Łódź continues developing the National Centre of Film Culture under its EU funded expansion programme, further exhibition, fit-out and multimedia integration contracts are a reasonable expectation, offering continued opportunities for specialist firms in this niche. Opportunities for Suppliers Exhibition fabrication and multimedia integration firms should note the rigour of this tender's sample based evaluation process as a likely template for future EC1 Łódź procurements and should be prepared to invest meaningfully in physical and conceptual sample submissions to compete credibly on quality criteria of this kind. What Businesses Should Watch Further exhibition and fit-out tenders from EC1 Łódź as its National Centre of Film Culture expansion continues. Whether TDC Polska pursues any further legal avenues following the Appeals Chamber's partial ruling. Broader use of Poland's European Funds for Infrastructure, Climate and Environment 2021-2027 programme to support cultural sector procurement. PolandTenders.com Procurement Intelligence This notice is a genuinely instructive case study in how procurement appeal mechanisms function in practice. A losing bidder's challenge succeeded, in part, in identifying a real procedural gap, insufficient documentation of quality scoring and Poland's National Appeals Chamber enforced a correction. But the correction did not change the substantive outcome, a reminder that procedural fairness and commercial outcome are related but distinct questions and that winning a partial appeal does not guarantee winning the contract. For contracting authorities, the lesson is straightforward: when quality criteria are assessed through samples or subjective judgment, as they were here, documenting the factual basis for every score awarded is not optional paperwork, it is a legal requirement that can determine whether an award decision survives challenge. For bidders considering an appeal, this case shows that a partial win, even one that forces a contracting authority back to the drawing board, does not automatically translate into a different result. For suppliers in the exhibition and cultural infrastructure space, the deeper signal is that Polish cultural institutions running EU co-financed projects are applying real rigour to technical and quality evaluation, using physical samples rather than paper proposals alone. Firms competing in this niche should treat sample preparation as seriously as pricing strategy. Supplier Takeaways This tender required physical and written evaluation samples alongside bids, a rigorous but replicable model for future exhibition fit-out competitions. A formal legal challenge partially succeeded on documentation grounds but did not change the substantive award outcome, illustrating the limits of procedural appeals. The winning bid was both the lowest priced and the highest scoring overall, suggesting strong performance across both price and quality dimensions. Contracting authorities using subjective quality criteria must document their scoring justification thoroughly to withstand legal challenge. This project's EU co-financing signals continued funding availability for Polish cultural infrastructure expansion. Key Takeaways EC1 Łódź awarded a PLN 11 036 052 contract to build its EU co-financed "Mechanical Eye" exhibition to New Amsterdam Sp. z o.o. A rival bidder, TDC Polska, successfully appealed the original award decision, forcing a redo of the evaluation, which reached the same result. Award criteria combined 60 percent price with 40 percent quality, assessed through physical and conceptual sample submissions. Three tenders were received, with prices ranging from roughly PLN 11 million to PLN 13.2 million. The project is financed under Poland's European Funds for Infrastructure, Climate and Environment 2021-2027 programme, supporting the National Centre of Film Culture's expansion. The winning bid included subcontracting, though the value and percentage involved are not disclosed. Conclusion Behind the routine language of a museum fit-out contract sits a small but genuine test of Poland's public procurement appeal system, one that worked broadly as intended: a legitimate procedural gap was identified and corrected, while the underlying commercial decision, reached on its merits across two rounds of evaluation, held firm. For EC1 Łódź and its National Centre of Film Culture, the result is a contractor now cleared, twice over, to bring the Mechanical Eye exhibition to life. Source: Tenders Electronic Daily (TED), Contract Award Notice 564089-2026, Official Journal of the European Union, OJ S 156/2026, published on 14 August 2026.
View Details
Rzeszów Hospital Secures Four Targeted Cancer Drugs Worth 16.5 Million Złoty
13 Aug 2026
Standfirst The Fryderyk Chopin University Clinical Hospital in Rzeszów has awarded four separate contracts for specialist cancer medicines, worth a combined 16.5 million złoty, to Janssen-Cilag Polska, Asclepios and Komtur Polska. Each of the four drug lots drew only a single tender. Introduction Cancer patients on targeted therapies often depend on a very specific medicine, one with no interchangeable substitute, delivered through structured national drug programmes rather than a general pharmacy. Securing supply of these medicines is a distinct and specialised category of hospital procurement. The Fryderyk Chopin University Clinical Hospital in Rzeszów has just closed exactly this kind of tender, securing a year's supply of four separate oncology medicines used within Poland's drug programme system. Why This Contract Matters Each of the four lots in this tender corresponds to a single named medicine used in targeted cancer treatment, reflecting how modern oncology increasingly relies on precision therapies matched to specific tumour types and genetic markers rather than broad spectrum chemotherapy alone. Because these are single source, drug specific lots rather than generic pharmaceutical categories, supply continuity for each individual medicine directly affects whether patients on that specific treatment protocol can continue their care without interruption. Contract Timeline This procedure follows an earlier related notice referenced as 358939-2026. All four winners were selected on the same date, 6 August 2026, and all four contracts were concluded five days later, on 11 August 2026. The notice recording these awards was dispatched on 12 August 2026 and published in the Official Journal of the European Union on 13 August 2026, under OJ S issue 155/2026. Each contract covers a 12 month supply period from the date of conclusion. Contract Overview Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie ran an open procedure under Directive 2014/24/EU and article 132 of Poland's Public Procurement Law for the purchase and successive delivery of medicines from drug programmes. The classification is CPV code 33652100, Antineoplastic agents, the category covering cancer treating medicines. The procurement is divided into four lots, each covering a single named medicine. One notable inconsistency appears in the notice itself: Lot 1 is titled Część nr 1, Avelumabum, referring to the drug avelumab, but its detailed description instead lists amivantamab, a different medicine entirely. This discrepancy is recorded as it appears in the notice, and the contracting authority has not clarified which drug the lot actually covers. Combined awarded values across the four lots total 16,541,507.22 PLN excluding VAT. Each of the four lots received exactly one tender, meaning none of the awards involved price competition between rival bidders. Key Contract Details Contracting AuthorityUniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie Procedure TypeOpen procedure, not accelerated Legal BasisDirective 2014/24/EU and article 132 of Poland's Public Procurement Law CPV Code33652100 Antineoplastic agents Lot 1Titled Avelumabum, described as amivantamab, awarded 5,915,520.00 PLN to Janssen-Cilag Polska Lot 2Lazertinib, awarded 4,509,999.22 PLN to Janssen-Cilag Polska Lot 3Serplulimab, awarded 3,549,728.00 PLN to Asclepios S.A. Lot 4Pemigatinib, awarded 2,566,260.00 PLN to Komtur Polska Combined Awarded Value (excl VAT)16,541,507.22 PLN Tenders Received1 per lot, all four lots Supply Period12 months per lot from contract conclusion Winners Selected6 August 2026, uniformly across all four lots Contracts Concluded11 August 2026, uniformly across all four lots Place of PerformanceRzeszów, Podkarpackie region (NUTS PL823), Poland Review OrganisationKrajowa Izba Odwoławcza (National Appeal Chamber) Project Scope Each lot covers the purchase and successive delivery, over a 12 month period, of a single named medicine administered through Poland's structured drug programme system, the national framework governing reimbursement and clinical access to high cost specialist medicines, particularly in oncology. The hospital does not permit equivalent or substitute products for these lots, reflecting how tightly these therapies are tied to specific clinical protocols and reimbursement rules under Poland's medicines refunding legislation. Supply quantities for each medicine are set out in detailed pricing and offer forms referenced in the tender documents but not reproduced in the public notice. About the Contracting Authority Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie The Fryderyk Chopin University Clinical Hospital in Rzeszów is a body governed by public law with health as its classified activity, based in Rzeszów in Poland's Podkarpackie region. As a university clinical hospital, it provides specialist care including oncology treatment requiring access to targeted, drug programme medicines of the kind covered in this tender. About the Organisations Involved Janssen-Cilag Polska Spółka z ograniczoną odpowiedzialnością Janssen-Cilag Polska, based in Warsaw and classified as a large enterprise, won both Lot 1 and Lot 2, with a combined awarded value of 10,425,519.22 PLN. Janssen-Cilag is the Polish affiliate of Janssen, the pharmaceutical division of Johnson & Johnson, and its position as sole tenderer on both lots reflects its role as the marketing authorisation holder for these specific medicines in Poland. ASCLEPIOS Spółka Akcyjna Asclepios S.A., based in Wrocław and classified as a large enterprise, won Lot 3, covering serplulimab, with an awarded value of 3,549,728.00 PLN. Asclepios operates as a pharmaceutical distributor within the Polish hospital medicines supply market. Komtur Polska Spółka z ograniczoną odpowiedzialnością Komtur Polska, based in Warsaw, won Lot 4, covering pemigatinib, with an awarded value of 2,566,260.00 PLN. Komtur is an established distributor of specialist pharmaceuticals within Poland's hospital sector. Krajowa Izba Odwoławcza Krajowa Izba Odwoławcza, Poland's National Appeal Chamber, operating under the Public Procurement Office in Warsaw, is named as the review organisation for this procurement, the standard body for hearing Polish public procurement disputes. Procurement Analysis Every one of the four lots in this tender attracted exactly one tender, meaning none of the awards involved competitive price pressure from a rival bidder. This is a common and expected pattern for single source, patented specialist medicines, where typically only the marketing authorisation holder or its appointed distributor is in a position to supply a given named drug at all. The Lot 1 title and description mismatch, listing avelumab in the title but amivantamab in the detailed description, is a data quality issue worth flagging clearly rather than assuming which drug the lot actually covers. Readers and market participants relying on this notice for competitive intelligence should treat this lot's actual subject matter as uncertain pending clarification from the contracting authority. Additional Procurement Facts The hospital does not accept equivalent product substitutions on any of these lots, reflecting the clinical specificity of drug programme medicines. Supply contracts run for 12 months, with the buyer reserving the right to extend the term through a contract annex if the full quantity ordered has not been delivered within the original period. Market and Industry Perspective Poland's drug programme system channels access to expensive, targeted oncology medicines through structured national reimbursement pathways, and hospital procurement of this kind reflects how individual hospitals then secure their specific allocation of these medicines through single source, sole tenderer contracts with the relevant marketing authorisation holder or distributor. Economic Significance At a combined 16.5 million złoty across four medicines, this procurement represents a meaningful, recurring cost for the Rzeszów hospital's oncology service, reflecting the high unit cost typical of targeted cancer therapies compared with older, more broadly available chemotherapy agents. Future Procurement Opportunities With each contract running for 12 months, the hospital is likely to return to the market for renewed supply of these same drug programme medicines on an annual cycle, following the same single source tender pattern seen in this award. Opportunities for Suppliers Because these are single source, patented specialist medicines, direct competitive opportunity for other suppliers is inherently limited to whichever company holds marketing authorisation or distribution rights for each specific drug. Distributors active in Poland's specialist pharmaceutical market should ensure they hold current distribution agreements for oncology drug programme medicines to remain eligible bidders for tenders of this kind. What Businesses Should Watch Pharmaceutical distributors and marketing authorisation holders active in Poland's oncology drug programme segment should watch for the annual renewal of these four specific medicine contracts, and should monitor for clarification on the Lot 1 title and description discrepancy identified in this notice. PolandTenders.com Procurement Intelligence This award illustrates the routine but essential mechanics behind Poland's drug programme system, individual hospitals running annual, single source tenders to secure specific targeted cancer medicines, each typically drawing only one eligible bidder given the patented, non-substitutable nature of these therapies. Its strategic importance lies less in competitive dynamics, since none existed here, and more in supply chain reliability. For patients on these specific treatment protocols, uninterrupted access depends on hospitals successfully renewing contracts like these on an annual basis with the sole eligible supplier for each medicine. The data inconsistency on Lot 1, where the stated title and the detailed description name two different medicines, is a useful reminder for anyone tracking pharmaceutical procurement data that even official contract award notices can contain internal contradictions that warrant direct clarification from the buyer rather than assumption. Supplier Takeaways All four lots drew exactly one tender each, consistent with the single source nature of patented, drug programme medicines Janssen-Cilag Polska secured two of the four lots, reflecting its role as marketing authorisation holder for those specific medicines in Poland Lot 1 contains an unresolved discrepancy between its stated title, avelumab, and its detailed description, amivantamab Contracts run for 12 months with a possible extension if quantities are not fully delivered within that period No equivalent product substitutions are accepted, reinforcing the single source nature of these specific medicine tenders Key Takeaways Rzeszów's Fryderyk Chopin University Clinical Hospital has awarded four cancer medicine contracts worth a combined 16,541,507.22 PLN Janssen-Cilag Polska won two lots, Asclepios S.A. won one, and Komtur Polska won one Each lot received only a single tender, and all four contracts were concluded on 11 August 2026 Lot 1 carries an unresolved naming discrepancy between avelumab in the title and amivantamab in the description Each contract covers a 12 month medicine supply period Conclusion This award secures a year's supply of four specialist cancer medicines for patients under the Rzeszów hospital's care, delivered through Poland's structured drug programme system. With each lot drawing only a single bidder, the real story here is supply chain continuity rather than competitive pricing. For pharmaceutical distributors and marketing authorisation holders in this space, the pattern is clear: renewal tenders of this kind will recur annually, and success depends on maintaining the specific distribution rights needed to remain the sole eligible bidder for each named medicine. Source: Tenders Electronic Daily (TED), Contract Award Notice 562334-2026, Official Journal of the European Union, OJ S issue 155/2026, published on 13/08/2026.
View Details
Podlaskie Region Orders Two Hybrid Trains from Newag in a 353.5 Million Złoty Deal
12 Aug 2026
Standfirst Województwo Podlaskie has awarded Polish rail manufacturer Newag S.A. a contract worth 353.5 million złoty to build two hybrid drive multi unit rail vehicles for passenger services in northeastern Poland. Newag was the only company to bid and it took nearly six months from selection to final contract signature. Introduction Rural and regional rail lines across Poland often lack full electrification, leaving passengers dependent on diesel trains that are noisier, less efficient and more polluting than their electric counterparts. Hybrid drive trains offer a middle path, running on electric power where overhead lines exist and switching to onboard power where they do not. Województwo Podlaskie, the regional government of Podlaskie in northeastern Poland, has just ordered two such trains, a purchase that will shape passenger rail service in the region for years to come. Why This Contract Matters Hybrid trains let regional authorities extend better quality rail service onto lines that would otherwise need expensive, time consuming electrification work before modern electric trains could run on them. For a region like Podlaskie, this kind of flexible rolling stock can improve passenger rail connectivity without waiting years for infrastructure upgrades. The contract is also EU funded, reflecting how European regional development support continues to underpin rail modernisation projects across Poland's less densely served regions. Contract Timeline This procedure follows an earlier related notice referenced as 851510-2025. The winner was selected on 20 February 2026, but the contract was not formally concluded until 4 August 2026, a gap of more than five months. Delivery of the vehicles is scheduled to run from 20 February 2026 through to 30 September 2029. The notice recording this award was dispatched on 11 August 2026 and published in the Official Journal of the European Union on 12 August 2026, under OJ S issue 154/2026. Contract Overview Województwo Podlaskie ran an open procedure under Directive 2014/24/EU for the purchase of two multi unit rail vehicles with hybrid drive for passenger transport services. The classification is CPV code 34620000, Rolling stock. The contract also includes a disclosed option right, described in the tender's contract template annex, though the specific terms of that option are not detailed in the public notice. The confirmed value of the contract, matching the winning tender exactly, is 353,502,000.00 PLN excluding VAT. Only one tender was received, from Newag S.A., meaning this contract was awarded without price competition from a rival bidder. Key Contract Details Contracting AuthorityWojewództwo Podlaskie Winning BidderNewag S.A. Contract TitlePurchase of two multi unit rail vehicles with hybrid drive for passenger transport services Procedure TypeOpen procedure, not accelerated Legal BasisDirective 2014/24/EU CPV Code34620000 Rolling stock Awarded Value (excl VAT)353,502,000.00 PLN Award CriteriaPrice 60 percent, delivery deadline 24 percent, warranty terms 10 percent, cab door design 6 percent Delivery and Service Period20 February 2026 to 30 September 2029 Tenders Received1, submitted electronically EU FundingFully or partially financed with EU funds Covered by GPANo SubcontractingNo Winner Selected20 February 2026 Contract Concluded4 August 2026 Review OrganisationKrajowa Izba Odwoławcza (National Appeal Chamber) Project Scope The contract covers the design and manufacture of two multi unit rail vehicles equipped with hybrid drive, capable of running on both electrified and non electrified sections of track, for use in passenger transport services within Podlaskie Voivodeship. Full technical specifications are set out in the tender's description of the contract subject matter, referenced as Annex 1 to the tender specifications, though this detail is not reproduced in the public notice itself. One specific technical requirement scored in the award criteria stands out: external doors to the driver's cabin, a design feature that affects crew access and safety and which carried a specific, if modest, 6 percent weight in the evaluation. About the Contracting Authority Województwo Podlaskie Województwo Podlaskie is a regional authority with general public services as its classified activity, responsible for regional government functions across the Podlaskie region in northeastern Poland, including regional passenger rail services. Its rolling stock investments directly shape the quality and reach of rail transport available to residents across the region. About the Organisations Involved Newag S.A. Newag S.A., based in Nowy Sącz and classified as a large enterprise, is one of Poland's established rail rolling stock manufacturers. It won this contract as the sole tenderer, with its bid ranked first by default and declared no subcontracting, meaning it will manufacture and deliver the two hybrid vehicles directly. Krajowa Izba Odwoławcza Krajowa Izba Odwoławcza, Poland's National Appeal Chamber, based in Warsaw, is named as the review organisation for this procurement. Polish procurement law sets out detailed appeal deadlines, generally 10 or 15 days depending on how information about a contested decision was communicated, with further recourse available through the Regional Court in Warsaw acting as the public procurement court for appeals against Chamber rulings. Procurement Analysis Województwo Podlaskie ran this as an open procedure, yet only one tender was received, from Newag S.A. This outcome, an open competition that draws a single bidder, is a notable market signal for specialised rolling stock procurements of this kind, where the number of manufacturers capable of delivering hybrid drive rail vehicles to a specific regional specification may be genuinely limited. Award criteria weighted price at 60 percent, with the remaining 40 percent split across three quality factors: delivery deadline at 24 percent, warranty and extended defect liability terms at 10 percent and a specific cabin door design requirement at 6 percent. The strong weighting on delivery deadline is notable, suggesting the region placed real value on getting these vehicles into service promptly rather than accepting extended lead times. The roughly five and a half month gap between winner selection in February 2026 and contract conclusion in August 2026 is longer than typical for most public contracts, though for large, bespoke rolling stock orders requiring detailed technical specification and contract negotiation, this kind of extended finalisation period is not unusual. Additional Procurement Facts The contract is confirmed as fully or partially financed with EU funds and is not covered by the Government Procurement Agreement. No framework agreement or dynamic purchasing system applies. No subcontracting was declared by Newag and none of the tender came from SMEs or from tenderers registered outside Poland, reflecting the highly specialised, domestically concentrated nature of the Polish rail rolling stock manufacturing sector. Market and Industry Perspective Newag is a well established name in the Polish and broader Central European rail rolling stock market and its position as sole bidder for this contract reflects the specialised, capital intensive nature of hybrid rail vehicle manufacturing, a segment with relatively few credible domestic or international suppliers able to meet the full technical, certification and delivery requirements of a regional Polish rail authority. The EU funding attached to this contract also reflects a broader pattern of European structural and regional development support continuing to underpin rolling stock modernisation across Poland's regional rail networks, particularly where hybrid technology can extend service improvements onto non-electrified lines without requiring costly infrastructure electrification first. Economic Significance At 353.5 million złoty for two vehicles, this is a substantial capital investment in Podlaskie's regional rail fleet, underscoring the high unit cost of specialised, technically advanced rolling stock. For Newag, it secures a significant order that reinforces its position as a leading domestic rail vehicle supplier. Future Procurement Opportunities Given that this contract includes an undisclosed option right, Podlaskie Voivodeship may be positioned to order additional vehicles or services under the same contract terms without running a fresh competitive tender, depending on how that option is structured. Beyond that, further Polish regional rail authorities pursuing similar hybrid or electrification linked rolling stock upgrades are likely to bring comparable tenders to market in the coming years. Opportunities for Suppliers Rail rolling stock manufacturers, whether domestic Polish firms or international operators, should note that this open tender drew only one bidder despite being fully open to competition, suggesting a genuine opportunity for additional credible suppliers to enter this specific segment of the Polish regional rail market if they can meet the technical and certification bar required. What Businesses Should Watch Rail manufacturers and suppliers should watch for how Podlaskie Voivodeship and other Polish regional authorities structure future hybrid and regional rolling stock tenders and should monitor whether the option right disclosed in this contract is exercised, since that would signal further order volume without a new competitive process. PolandTenders.com Procurement Intelligence This award illustrates how Polish regional authorities are using hybrid drive rolling stock to modernise passenger rail service on lines that lack full electrification, a practical middle path that extends service improvements without requiring costly infrastructure investment first. The EU funding behind this contract confirms its alignment with broader European regional development priorities. Its strategic importance lies in what the single bidder outcome reveals about the Polish rail manufacturing market. Despite running a fully open procedure, Podlaskie received interest from only one supplier, a signal that the pool of manufacturers capable of delivering hybrid rail vehicles to a specific regional specification remains genuinely narrow, even in a country with an established domestic rolling stock industry like Poland. Suppliers can draw a clear lesson from the weighting behind this award. With delivery deadline carrying 24 percent of the total score, well above the 10 percent given to warranty terms, this buyer placed real value on getting new trains into passenger service quickly, a priority that manufacturers bidding for similar future contracts should factor prominently into their own proposals. Supplier Takeaways Only one tender was received despite this being a fully open procurement procedure, suggesting limited current competition in this specific rolling stock segment Award criteria weighted price at 60 percent, with delivery deadline carrying a notable 24 percent, well above warranty terms at 10 percent The contract includes an undisclosed option right that could lead to further orders without a new competitive tender No subcontracting was declared, indicating Newag will manufacture and deliver the vehicles directly The contract is EU funded, reflecting continued European support for regional rail modernisation in Poland Key Takeaways Województwo Podlaskie has awarded Newag S.A. a contract worth 353,502,000.00 PLN for two hybrid drive multi unit rail vehicles Newag was the sole tenderer in this open procedure Award criteria weighted price at 60 percent and split the remaining 40 percent across delivery deadline, warranty terms and a cabin door design requirement Nearly six months passed between winner selection in February 2026 and contract conclusion in August 2026 The contract is EU funded and vehicle delivery runs through September 2029 Conclusion This contract brings two new hybrid drive trains to Podlaskie's regional rail network, a practical step toward better passenger service on lines that do not yet have full electrification. For Newag, it is a significant order that reinforces its role as a leading Polish rail rolling stock manufacturer. For the wider Polish rail sector, the single bidder outcome here is worth watching closely, a reminder that even in an established domestic rolling stock industry, highly specialised orders like hybrid drive trains can still draw limited competitive interest. Source: Tenders Electronic Daily (TED), Contract Award Notice 558325-2026, Official Journal of the European Union, OJ S issue 154/2026, published on 12/08/2026.
View Details